by admin | Oct 28, 2019 | Funding
Pepticom’s unique artificial intelligence (AI) technology streamlines and significantly accelerates the ability of researchers to discover advanced peptide-based drug candidates. Peptides are used in various therapies, and are recognized for being highly...
by admin | Oct 21, 2019 | Funding
AI-driven drug repurposing company Healx Ltd (Cambridge, UK) raises US$56m in a Series B financing and launches global accelerator programme for orphan diseases. The financing was led by Atomico and joined by Intel Capital, Global Brain and btov Partners as new...
by admin | Sep 17, 2019 | M&A - Buy-Out
Varian said it is investing in privately held Oncora Medical and will partner with the software company to develop machine learning-guided decision support tools. The aim is to help doctors create personalized treatment plans for cancer patients. Financial terms...
by admin | Sep 17, 2019 | FDA
GE Healthcare has received 510(k) clearance for AI algorithms designed to detect a type of collapsed lung on x-ray images. The FDA clearance covers a set of algorithms that GE has embedded in its Optima XR240amx mobile x-ray device, thereby enabling hospitals to...
by admin | Sep 11, 2019 | Partnerships
Atomwise, the leader in artificial intelligence (AI) for drug discovery, today announced a collaboration with Hansoh Pharmaceutical Group Company Limited (“Hansoh Pharma”), a leading biopharmaceutical company in China, to design and discover potential drug candidates...
